Literature DB >> 21820477

Cost-effectiveness and socio-economic aspects of childhood influenza vaccination.

Kristin L Nichol1.   

Abstract

Children have high rates of healthcare utilization due to influenza. In addition, children also transmit influenza to others in their households and the community. The costs of influenza in children include the direct medical care costs from increased outpatient visits and hospitalizations, and also indirect costs due to productivity losses especially for their parents and due to transmission of the virus to others. A variety of studies using different methods and assumptions have assessed the cost-effectiveness of influenza vaccination of children, and many find that vaccination is either cost saving or cost effective. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21820477     DOI: 10.1016/j.vaccine.2011.08.015

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Economic benefits of inactivated influenza vaccines in the prevention of seasonal influenza in children.

Authors:  Luis Salleras; Encarna Navas; Nuria Torner; Andreu A Prat; Patricio Garrido; Núria Soldevila; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

Review 2.  Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies.

Authors:  Mark Jit; Anthony T Newall; Philippe Beutels
Journal:  Hum Vaccin Immunother       Date:  2013-01-28       Impact factor: 3.452

3.  Safety of guidelines recommending live attenuated influenza vaccine for routine use in children and adolescents with asthma.

Authors:  James D Nordin; Gabriela Vazquez-Benitez; Avalow Olsen; Leslie C Kuckler; Ashley Y Gao; Elyse O Kharbanda
Journal:  Vaccine       Date:  2019-06-10       Impact factor: 3.641

4.  Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.

Authors:  Rebecca J Hart; Michelle D Stevenson; Michael J Smith; A Scott LaJoie; Keith Cross
Journal:  JAMA Pediatr       Date:  2018-01-02       Impact factor: 16.193

Review 5.  Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.

Authors:  Jördis J Ott; Janna Klein Breteler; John S Tam; Raymond C W Hutubessy; Mark Jit; Michiel R de Boer
Journal:  Hum Vaccin Immunother       Date:  2013-05-31       Impact factor: 3.452

Review 6.  Prevention of influenza in healthy children.

Authors:  Bruce Y Lee; Mirat Shah
Journal:  Expert Rev Anti Infect Ther       Date:  2012-10       Impact factor: 5.091

7.  Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V ® and Fluad ® ) in preventing hospitalization for influenza and pneumonia in the elderly: a matched case-control study.

Authors:  Roberto Gasparini; Daniela Amicizia; Piero Luigi Lai; Stefania Rossi; Donatella Panatto
Journal:  Hum Vaccin Immunother       Date:  2012-11-10       Impact factor: 3.452

8.  Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany.

Authors:  Oliver Damm; Martin Eichner; Markus Andreas Rose; Markus Knuf; Peter Wutzler; Johannes Günter Liese; Hagen Krüger; Wolfgang Greiner
Journal:  Eur J Health Econ       Date:  2014-05-25

9.  Socio-economic burden of influenza among children younger than 5 years in the outpatient setting in Suzhou, China.

Authors:  Dan Wang; Tao Zhang; Jing Wu; Yanwei Jiang; Yunfang Ding; Jun Hua; Ying Li; Jun Zhang; Liling Chen; Zijian Feng; Danielle Iuliano; Jeffrey McFarland; Genming Zhao
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

10.  Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design.

Authors:  Denise A Kaminski; F Eun-Hyung Lee
Journal:  Front Immunol       Date:  2011-12-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.